Literature DB >> 9420697

Current status of viability assessment with positron tomography.

N Tamaki1.   

Abstract

Accurate detection of reversible myocardium has great clinical importance, especially in patients being considered for interventional therapy. Positron emission tomography (PET) with fluorine 18-labeled fluorodeoxyglucose (FDG) has been used for this purpose, based on the residual metabolic activity in reversible ischemic areas. Although thallium imaging has been widely used for the evaluation of tissue viability in clinical cardiology, PET-FDG may provide independent values and thus may enhance the accuracy of studies for identifying ischemic myocardium. This review considers the advantages of PET technique, the clinical value of PET-FDG for assessing tissue viability, and the development of other new PET techniques.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 9420697     DOI： 10.1007/bf02940068

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


  46 in total

1.  Myocardial FDG PET studies with the fasting, oral glucose-loading or insulin clamp methods.

Authors:  N Tamaki; Y Yonekura; J Konishi
Journal:  J Nucl Med       Date:  1992-07       Impact factor: 10.057

2.  The hibernating myocardium.

Authors:  S H Rahimtoola
Journal:  Am Heart J       Date:  1989-01       Impact factor: 4.749

Review 3.  Myocardial utilization of carbohydrate and lipids.

Authors:  J R Neely; M J Rovetto; J F Oram
Journal:  Prog Cardiovasc Dis       Date:  1972 Nov-Dec       Impact factor: 8.194

4.  Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging.

Authors:  N Tamaki; M Kawamoto; N Takahashi; Y Yonekura; Y Magata; R Nohara; H Kambara; S Sasayama; K Hirata; T Ban
Journal:  J Am Coll Cardiol       Date:  1993-11-15       Impact factor: 24.094

5.  Delineation of myocardial oxygen utilization with carbon-11-labeled acetate.

Authors:  M Brown; D R Marshall; B E Sobel; S R Bergmann
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

6.  Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography.

Authors:  M A Brown; D W Myears; S R Bergmann
Journal:  J Am Coll Cardiol       Date:  1988-10       Impact factor: 24.094

7.  Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model.

Authors:  M Schwaiger; H R Schelbert; D Ellison; H Hansen; L Yeatman; J Vinten-Johansen; C Selin; J Barrio; M E Phelps
Journal:  J Am Coll Cardiol       Date:  1985-08       Impact factor: 24.094

8.  Increased uptake of 18F-fluorodeoxyglucose in postischemic myocardium of patients with exercise-induced angina.

Authors:  P Camici; L I Araujo; T Spinks; A A Lammertsma; J C Kaski; M J Shea; A P Selwyn; T Jones; A Maseri
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

9.  Regional myocardial metabolism in patients with acute myocardial infarction assessed by positron emission tomography.

Authors:  M Schwaiger; R Brunken; M Grover-McKay; J Krivokapich; J Child; J H Tillisch; M E Phelps; H R Schelbert
Journal:  J Am Coll Cardiol       Date:  1986-10       Impact factor: 24.094

Review 10.  Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography.

Authors:  P Camici; E Ferrannini; L H Opie
Journal:  Prog Cardiovasc Dis       Date:  1989 Nov-Dec       Impact factor: 8.194
View more
  2 in total

Review 1.  Cardiac metabolism: a technical spectrum of modalities including positron emission tomography, single-photon emission computed tomography, and magnetic resonance spectroscopy.

Authors:  R Valkema; B L van Eck-Smit; E E van der Wall
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

2.  Prognostic value of iodine-123 labelled BMIPP fatty acid analogue imaging in patients with myocardial infarction.

Authors:  N Tamaki; E Tadamura; T Kudoh; N Hattori; Y Yonekura; R Nohara; S Sasayama; K Ikekubo; H Kato; J Konishi
Journal:  Eur J Nucl Med       Date:  1996-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.